Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Key Clinical Findings from Rose Pharma Studies: Proven Appetite Suppression: Completed proof of concept study, demonstrated that ROSE-010 significantly reduces food consumption and slows gastric emptying Rapid Onset, Short Duration: Begins working within 20 minutes and clears within a few hours, minimizing side effects Reduced GI Side Effects: Unlike long-acting GLP-1s, ROSE-010s shorter half-life lowers the period of nausea and GI distress Improved Tolerability: Targets appetite without prolonged drug exposure, making it an ideal maintenance therapy Why the Market Needs ROSE-010 60-85% of GLP-1 patients need an effective weight loss maintenance strategy Current solutions focus on weight lossPeople need long-term weight loss management options ROSE-010 offers a flexible, meal-time approach to prevent weight regain Real-world data shows that long-term GLP-1 adherence is low yet patients need tools to sustain their progress
Craig CM, McLaughlin TL
Start your custom plan here
What is needed is a food noise control product
If you want a focused look at semaglutide and donation rules, our donating plasma while taking semaglutide guide covers the same question from another angle
Im 67 and I Im so glad I found Whitney and followed her to Total Skin
